Prostate cancer detection: magnetic resonance (MR) spectroscopic imaging.
Magnetic resonance spectroscopic imaging (MRSI) represents a noninvasive technique to extend the diagnostic evaluation of prostatic cancer, beyond the morphologic information provided by MR imaging throughout the detection of cellular metabolites (choline and citrate). MRSI combined with the anatomical information provided by MRI can improve the assessment cancer location and extent within the prostate, extracapsular spread and cancer aggressiveness; both before and after treatment. We review the performance of MRI with MRSI and the role in the detection, localization, staging and management of the patient pre- and posttherapy for prostate cancer.
Vilanova
Joan C
JC
Department of Magnetic Resonance, Clínica Girona, Lorenzana, 36, 17002 Girona, Spain. kvilanova@comg.es
Barceló
Joaquim
J
D006801:Humans; D018810:Magnetic Resonance Angiography; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D011471:Prostatic Neoplasms / Q000737:chemistry / Q000175:diagnosis*